Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1973 1
1975 1
1977 1
1987 7
1988 6
1989 3
1990 2
1991 2
1992 1
1993 1
1994 8
1995 8
1996 8
1997 2
1998 3
1999 1
2000 4
2002 1
2003 2
2004 2
2005 4
2006 2
2007 2
2008 2
2009 6
2010 5
2011 4
2012 2
2013 4
2014 2
2015 5
2016 10
2017 6
2018 10
2019 21
2020 25
2021 21
2022 24
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Research Ethics for Clinical Researchers.
Harnett JD. Harnett JD. Methods Mol Biol. 2021;2249:53-64. doi: 10.1007/978-1-0716-1138-8_4. Methods Mol Biol. 2021. PMID: 33871838
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Oaknin A, Monk BJ, Vergote I, Cristina de Melo A, Kim YM, Lisyanskaya AS, Samouëlian V, Kim HS, Gotovkin EA, Damian F, Chang CL, Takahashi S, Li J, Mathias M, Fury MG, Ivanescu C, Reaney M, LaFontaine PR, Lowy I, Harnett J, Chen CI, Tewari KS. Oaknin A, et al. Among authors: harnett j. Eur J Cancer. 2022 Oct;174:299-309. doi: 10.1016/j.ejca.2022.03.016. Epub 2022 Jul 31. Eur J Cancer. 2022. PMID: 35922251 Free article. Clinical Trial.
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Gümüş M, Chen CI, Ivanescu C, Kilickap S, Bondarenko I, Özgüroğlu M, Gogishvili M, Turk HM, Cicin I, Harnett J, Mastey V, Naumann U, Reaney M, Konidaris G, Sasane M, Brady KJS, Li S, Gullo G, Rietschel P, Sezer A. Gümüş M, et al. Among authors: harnett j. Cancer. 2023 Jan 1;129(1):118-129. doi: 10.1002/cncr.34477. Epub 2022 Oct 29. Cancer. 2023. PMID: 36308296 Free PMC article. Clinical Trial.
A Review of Mentorship in Urology: Are We Satisfied?
Chen A, Harnett J, Kothari P, Ernst M. Chen A, et al. Among authors: harnett j. Curr Urol Rep. 2022 Dec;23(12):383-392. doi: 10.1007/s11934-022-01122-9. Epub 2022 Dec 2. Curr Urol Rep. 2022. PMID: 36459377 Free PMC article. Review.
Acute vertigo: getting the diagnosis right.
Agarwal K, Harnett J, Mehta N, Humphries F, Kaski D. Agarwal K, et al. Among authors: harnett j. BMJ. 2022 Aug 12;378:e069850. doi: 10.1136/bmj-2021-069850. BMJ. 2022. PMID: 35961676 No abstract available.
211 results